Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 17/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9739962 | 0.95 | ADORA3 (0.56) | ADORA3ADORA1ADORA2ANR1H3 | |
| SCHEMBL9529988 | 0.83 | NR1H3 (0.54) | ADORA3ADORA1ADORA2ANR1H3 | |
| SCHEMBL9739965 | 0.78 | ADORA3 (0.57) | ADORA3ADORA1ADORA2ANR1H3 | |
| SCHEMBL6716491 | 0.72 | ADORA3 (0.93) | ADORA3ADORA1ADORA2AMAPT | |
| SCHEMBL9528025 | 0.72 | XDH (0.33) | ADORA3ADORA1ADORA2AGPR84SMN1; SMN2 | |
| SCHEMBL8105628 | 0.72 | PDE4A (0.42) | ADORA3ADORA1ADORA2A | |
| SCHEMBL6718573 | 0.72 | ADORA3 (0.90) | ADORA3ADORA1ADORA2AMAPT | |
| SCHEMBL28827848 | 0.70 | GPR84 (0.58) | ADORA3ADORA1ADORA2ANR1H3GPR84 | |
| SCHEMBL28327919 | 0.69 | GPR84 (0.57) | ADORA3ADORA2ANR1H3GPR84TP53 | |
| SCHEMBL14118418 | 0.69 | HDAC1 (0.48) | ADORA3ADORA1ADORA2ANR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | disclosed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | disclosed |